TGFβ is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction

被引:52
作者
Byrne, Scott N. [1 ]
Knox, Matthew C. [1 ]
Halliday, Gary M. [1 ]
机构
[1] Univ Sydney, Royal Prince Alfred Hosp, Sydney Canc Ctr, Melanoma & Skin Canc Res Inst,Dermatol Res Unit, Sydney, NSW 2006, Australia
关键词
tumour-associated macrophages; dendritic cells; skin; cytokines; tumour immunity;
D O I
10.1038/sj.icb.7100116
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Infiltration of skin tumours by macrophages is an important step in tumour progression, although the mechanisms of macrophage recruitment to the tumour mass and the subsequent effects on tumour growth are poorly understood. Transfecting a murine regressing skin tumour with the gene for transforming growth factor (TGF)beta enabled the tumours to grow progressively in vivo thus allowing us to study the role of this cytokine in tumour growth. Flow cytometry was used to show that TGF beta-mediated tumour progression was accompanied by an increase in tumour-associated macrophages (TAM) and a decrease in tumour-infiltrating dendritic cells (DCs). TAM in TGFb-secreting tumours expressed lower levels of major histocompatibility complex II and CD86 compared to DC in control tumours and had a high phagocytic capacity as measured by uptake of latex beads in vivo. Indeed, TGF beta was directly responsible not only for the enhanced macrophage phagocytosis but also altering the ratio of antigen-presenting cells to favour macrophages over DC. Our results demonstrate that TGFb recruitment and retention of macrophages at the tumour site enable effective tumour evasion of the host immune system and reinforces the need to target TGFb in human cancer immunotherapy trials.
引用
收藏
页码:92 / 97
页数:6
相关论文
共 29 条
[1]   Lack of effector cell function and altered tetramer binding of tumor-infiltrating lymphocytes [J].
Blohm, U ;
Roth, E ;
Brommer, K ;
Dumrese, T ;
Rosenthal, FM ;
Pircher, H .
JOURNAL OF IMMUNOLOGY, 2002, 169 (10) :5522-5530
[2]   Phagocytosis by dendritic cells rather than MHC IIhigh macrophages is associated with skin tumour regression [J].
Byrne, SN ;
Halliday, GM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (05) :736-744
[3]   Tumor-associated macrophages: The double-edged sword in cancer progression [J].
Chen, JJW ;
Lin, YC ;
Yao, PL ;
Yuan, A ;
Chen, HY ;
Shun, CT ;
Tsai, MF ;
Chen, CH ;
Yang, PC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (05) :953-964
[4]   Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells [J].
Dhodapkar, MV ;
Steinman, RM ;
Krasovsky, J ;
Munz, C ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :233-238
[5]   Tumor-induced immune dysfunction: The macrophage connection [J].
Elgert, KD ;
Alleva, DG ;
Mullins, DW .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (03) :275-290
[6]  
FAN K, 1992, BLOOD, V79, P1679
[7]  
Fujimoto J, 2000, CANCER RES, V60, P2632
[8]  
Geissmann F, 1999, J IMMUNOL, V162, P4567
[9]   Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma [J].
Goldszmid, RS ;
Idoyaga, J ;
Bravo, AI ;
Steinman, R ;
Mordoh, J ;
Wainstok, R .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5940-5947
[10]   Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype [J].
Hagemann, Thorsten ;
Wilson, Julia ;
Burke, Frances ;
Kulbe, Hagen ;
Li, Ninfeng Fiona ;
Pluddemann, Annette ;
Charles, Kellie ;
Gordon, Siamon ;
Balkwill, Frances R. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (08) :5023-5032